Unraveling Tourette's Syndrome: Genetic and Environmental Interactions, Diagnosis Challenges, and Emerging Treatments
Downloads
The human neural system constitutes the central control mechanism of the organism, overseeing the vast majority of human functions and their coordination. Neurological disorders disrupt its harmonious functioning, and as anticipated, it is imperative to investigate the underlying causes and devise appropriate interventions. Tourette's syndrome exemplifies a neuropsychiatric disorder, the full understanding of which remains elusive. The causative factors are shrouded in ambiguity, with evidence suggesting a convergence of both genetic and environmental elements. The multifaceted origins of Tourette's syndrome manifest in a spectrum of symptoms, ranging from mild to severe. This complexity, compounded by its comorbidity with disorders such as Attention Deficit Hyperactivity Disorder (ADHD) and Obsessive-Compulsive Disorder (OCD), complicates its diagnosis. Treatment modalities for the syndrome are diverse. While pharmacological treatment has proven considerably effective, it often comes with attendant side effects. In cases presenting mild symptoms, behavioral training techniques offer relief, whereas in instances of more severe manifestations, a neurosurgical procedure known as deep brain stimulation has recorded success.
Abelson, J. F., Kwan, K. Y., O’Roak, B. J., Baek, D. Y., Stillman, A. A., Morgan, T. M. et al. (2005). Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science, 310, 317-320.
American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.) (DSM-IV). Text Revision. Washington, DC: American Psychiatric Association.
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed) (DSM-V). Arlington, USA: American Psychiatric Publishing.
Brander, G., Rydell, M., Kuja-Halkola, R., Fernández de la Cruz, L., Lichtenstein, P., Serlachius, E. et al. (2018). Perinatal risk factors in Tourette’s and chronic tic disorders: a total population sibling comparison study. Molecular Psychiatry, 23, 1189–1197.
Cath, D. C., Hedderly, T., Ludolph, A. G., Stern, J. S., Murphy, T., Hartmann, A. et al. (2011). European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment. European Child and Adolescent Psychiatry, 20(4), 155–71.
Du, J. C., Chiu, T. F., Lee, K. M., Wu, H. L., Yang, Y. C., Hsu, S.Y. et al. (2010). Tourette syndrome in children: An updated review. Pediatrics & Neonatology, 51, 255-264.
Eldridge, R., Sweet, R., Lake, R., Ziegler, M., Shapiro, A.K. (1977). Gilles de la Tourette's syndrome: clinical, genetic, psychologic, and biochemical aspects in 21 selected families, Neurology, 27, 115-124.
Ercan-Sencicek, A. G., Stillman, A. A., Ghosh, A. K., Bilguvar, K., O'Roak, B. J., Mason, C. E. et al. (2010). L-histidine decarboxylase and Tourette's syndrome. New England Journal of Medicine, 362, 1901-1908.
Freeman, R. D., Fast, D. K., Burd, L., Kerbeshian, J., Robertson, M. M. et al. (2000). An international perspective on Tourette syndrome: Selected findings from 3500 individuals in 22 countries. Developmental Medicine &Child Neurology, 42, 436-447.
Gilson, F. (2012). Gilles de la Tourette: The history of the man and his illness; a medical historical study. Tijdschrift voor Psychiatrie, 54 (7), 427-36.
Hirschtritt, M.E., Lee, P.C., Lee Pauls, D.L., Dion, Y., Grados, M. A. et al. (2015) Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in tourette syndrome. JAMA Psychiatry, 72, 325-333.
Kastrup A., Schlotter W., Plewnia C., Bartels M. (2005). Treatment of tics in tourette syndrome with aripiprazole. The Journal of Clinical Psychopharmacology, 25, 94–96.
Kurlan, R., Como, P.G., Miller, B., Palumbo, D., Deeley, C., Andresen, E.M. et al. (2002). The behavioral spectrum of tic disorders: a community-based study. Neurology, 59, 414-420.
Lajonchere, C., Nortz, M., Finger, S. (1996). Gilles de la Tourette and the discovery of Tourette syndrome. Archives of neurology, 53 (6), 567-74.
Leckman, J. F., Hardin, M. T., Riddle, M. A., Stevenson, J., Ort, S. I. et al. (1991). Clonidine treatment of Gilles de la Tourette syndrome. Archives of General Psychiatry, 48, 324-328.
Mink, J.W. (2001). Basal ganglia dysfunction in Tourette's syndrome: a new hypothesis. Pediatric Neurology, 25 (3), 190-8.
Novotny, M., Valis, M., Klimova, B. (2018). Tourette Syndrome: A Mini-Review. Frontiers in Neurology, 9, 139.
Price, R.A., Kidd, K.K., Cohen, D.J., Pauls, D.L., Leckman, J.F. (1985). A twin study of Tourette syndrome. Archives of General Psychiatry, 42, 815-820.
Pringsheim, T., Okun, M. S., Muller-Vahl, K. et al. (2019). Practice guidelines recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 92 (19), 896–906.
Sandor, P., Musisï, S., Moldofsky, H., Lang, A. (1990). Tourette syndrome: a followup study. Τhe Journal of Clinical Psychopharmacology, 10, 197–199.
Scahill, L., Chappell, P. B., Kim, Y. S., Schultz, R. T., Katsovich, L. et al. (2001) A placebo-controlled study of guanfacine in the treatment of children with tic disorders and ADHD. American Journal of Psychiatry, 158, 1067-1074.
Singer, H.S., Hong, J.J., Yoon, D.Y., Williams, P.N. (2005). Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology, 65 (11), 1701–1707.
Zhang, H., Leckman, J. F., Pauls, D. L., Tsai, C. P., Kidd, K. K., Campos, M. R. et al. (2002). Genomewide scan of hoarding in sib pairs in which both sibs have Gilles de la Tourette syndrome. The American Journal of Human Genetics, 70, 896-904.
Copyright (c) 2024 Eirini Karagianni, Dimitrios Karakoulas
This work is licensed under a Creative Commons Attribution 4.0 International License.
All Content should be original and unpublished.
